Belzutifan is really a CYP2C19 substrate. Coadministration with CYP2C19 inhibitors may increase incidence or severity of adverse effects. Keep track of for anemia and hypoxia and lessen belzutifan dose as advisable. tecovirimat will enhance the stage or result of modafinil by influencing hepatic enzyme CYP2C19 metabolism. Use Caution/Watch. Tecovirimat https://modafinil21087.ageeksblog.com/25765468/new-step-by-step-map-for-modafinil